
BI-3406
CAS No. 2230836-55-0
BI-3406( —— )
Catalog No. M21998 CAS No. 2230836-55-0
BI-3406 is an orally active, highly potent and selective between KRAS and Son of Sevenless 1 (SOS1) interaction inhibitor(IC50 : 6 nM),with anticancer activity.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 147 | In Stock |
![]() ![]() |
10MG | 237 | In Stock |
![]() ![]() |
25MG | 439 | In Stock |
![]() ![]() |
50MG | 628 | In Stock |
![]() ![]() |
100MG | 871 | In Stock |
![]() ![]() |
500MG | 1737 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameBI-3406
-
NoteResearch use only, not for human use.
-
Brief DescriptionBI-3406 is an orally active, highly potent and selective between KRAS and Son of Sevenless 1 (SOS1) interaction inhibitor(IC50 : 6 nM),with anticancer activity.
-
DescriptionBI-3406 is an orally active, highly potent and selective between KRAS and Son of Sevenless 1 (SOS1) interaction inhibitor(IC50 : 6 nM),with anticancer activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
RecptorKRAS-SOS1|MAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2230836-55-0
-
Formula Weight462.46
-
Molecular FormulaC23H25F3N4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:95mg/ml (205.42 Mm; Need ultrasonic);Ethanol:100 mg/mL (216.23 mM; Need ultrasonic
-
SMILESCOC1=C(O[C@H]2CCOC2)C=C2C(N[C@H](C)C3=CC(=CC(N)=C3)C(F)(F)F)=NC(C)=NC2=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Marco H Hofmann, et al. Abstract PL06-01: Discovery of BI-3406: A potent and selective SOS1::KRAS inhibitor opens a new approach for treating KRAS-driven tumors. December 2019.2. Michael Gmachl, et al. Novel benzylamino substituted quinazolines and derivatives as sos1 inhibitors. WO2018115380A1.
molnova catalog



related products
-
KRAS G12C inhibitor ...
A potent, selective, covalent KRAS G12C inhibitor that selectively inhibit KRAS G12C-dependent signaling and cancer cell growth at sub-micromolar concentrations.
-
ML-210
A small-molecule probe that selectively kills cells induced to express mutant RAS; inhibits BJeLR (expressing HRAS G12V) cell lines with IC50 of 25 nM.
-
BAY-293 racemate
BAY-293 racemate (BAY293 racemate) is a potent SOS1 inhibitor that disrupts the KRAS-SOS1 interaction with IC50 of 50 nM。